Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs
Affiliate disclosure: we earn commission from some partners. Learn more.
Weight Loss· Editorial-reviewed against primary sources

What a GLP-1 program actually costs in 2026, and the one number nobody advertises

The sticker price you see is almost never the price you pay. Here is how to read a GLP-1 telehealth quote (platform fee, medication, and labs) before you hand over a card, and why the all-in monthly cost is the only figure that matters.

By WeighedHealth Editorial

3 min readUpdated

$0
cheapest branded self-pay /mo (LillyDirect)
$0+
retail list price /mo before discounts
$0+
old compounded floor, now restricted
0
costs to add up: fee, drug, labs

The one number that matters: all-in monthly cost

If you have shopped for semaglutide or tirzepatide online, you have seen the pattern. A big friendly number on the landing page ($99 a month, or 'from $149'), then a checkout total that looks nothing like it. The gap is not a glitch. It is the most important thing to understand about GLP-1 pricing, and it is why the FTC took action against a large telehealth weight-loss company over advertising a price that excluded the actual medication [1].

Before comparing programs, learn to compute the only figure that matters: all-in monthly cost. A real quote has to include three things: the platform or membership fee, the medication itself, and any required labs or add-ons. A quote that names only the fee is a teaser, not a price.

The 2026 price landscape

Without insurance or discounts, the branded drugs carry list prices in the four figures. Zepbound and Wegovy both list well above $1,000 per month at retail. Almost nobody pays that, because two things now sit underneath it.

First, manufacturer self-pay. Eli Lilly's LillyDirect sells Zepbound vials on a self-pay tier starting around $299 per month for the lowest dose and stepping up with dose; Novo Nordisk's NovoCare offers a comparable direct-pay path for Wegovy [2]. These bypass insurance and deliver the FDA-approved branded drug, not a compounded copy. Second, telehealth bundles that package a prescriber plus medication for a monthly fee. That is where the $99 headlines live, and where the medication-included question matters most.

The traps, plainly

The 'starting at' trap: GLP-1 doses escalate, so a price quoted at the 2.5 mg starter dose can climb as you titrate. Ask whether the price is flat across doses or rises.

The price-excludes-the-drug trap: if the medication is a separate line item you discover at checkout, the advertised number was never the price.

The compounded trap: after the FDA shortage ended, compounded GLP-1s are no longer a simple cheaper substitute, so a program marketing compounded semaglutide as an identical budget version of Wegovy is one to question.

How to actually compare

Pick three programs. For each, write down one number: total month-one cost with medication included, at the dose you will realistically be on by month three. Compare those three numbers. Everything else (the branding, the app, the concierge) is secondary. For a starting point on any single drug, our Zepbound savings breakdown and Wegovy savings breakdown lay out the manufacturer, telehealth, and discount-card options side by side.

Because doing this by hand across a dozen providers is tedious, WeighedHealth maintains a free, sourced comparison of what fifteen GLP-1 telehealth programs actually cost all-in: platform fee versus medication, brand-name versus compounded, and whether each names its dispensing pharmacy.

Sources

Primary sources cited above. FDA labeling, peer-reviewed trials, and specialty-society guidelines only.

  1. FTC Takes Action Against Telehealth Weight-Loss Advertising Practices · U.S. Federal Trade Commission, 2026
  2. Eli Lilly cuts Zepbound price to widen access for obesity drug · Reuters, 2025
  3. GLP-1 telehealth pricing dataset (2026): 15 providers, real all-in cost · WeighedHealth, 2026

People also ask

  • What is the cheapest way to get a GLP-1 in 2026?

    For the FDA-approved branded drug, manufacturer self-pay is usually the lowest legitimate route. Eli Lilly's LillyDirect sells Zepbound vials starting around $299 per month for the lowest dose, and Novo Nordisk's NovoCare offers a comparable path for Wegovy. Insurance with a manufacturer savings card can be cheaper still if your plan covers the drug. Telehealth membership bundles advertise lower headline numbers, but you have to confirm the medication is included in that price.

  • Why is the price at checkout higher than the advertised price?

    Because the advertised number often covers only the platform or membership fee, not the medication, labs, or higher doses you titrate up to. A quote that names only the membership fee is a teaser, not a price. The honest question to ask any program is what you will pay in total, medication included, in month one and month three.

  • Does the price go up as my dose increases?

    It can. GLP-1 doses escalate over the first months, and some programs price 'starting at' the 2.5 mg starter dose, so the cost climbs as you titrate. Other programs hold one flat price at every dose. On a drug you titrate up, flat-dose pricing is worth real money, so ask which model a program uses before committing.

Related reads

Share: